Plain-English translation of NCT07336446 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help treat advanced prostate cancer that has spread to other parts of the body. Researchers want to understand how safe the medication is, how your body processes it, and whether it can slow or stop cancer growth. Some participants will take this medication alone, while others may receive it combined with another cancer drug.
Men with advanced prostate cancer often need new treatment options, especially after other standard therapies stop working. This medication targets cancer cells in a different way than existing treatments, and this trial will determine whether it offers a real benefit for patients who need it most.
You will visit the research center regularly for check-ups, blood tests, and scans to monitor your cancer and watch for side effects. You will take the medication by mouth, either by itself or combined with another cancer drug, depending on which part of the trial you join. Treatment continues until your cancer gets worse, you experience unacceptable side effects, or you decide to stop—which could be weeks, months, or longer depending on how well the medication works for you.
AI-generated summary from trial data · Aug 21, 2026 · Not medical advice
United States
Australia
Japan
United Kingdom